Beam Therapeutics Inc.Beam Therapeutics Inc.Beam Therapeutics Inc.

Beam Therapeutics Inc.

No trades
See on Supercharts

BEAM fundamentals

Beam Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of BEAM for the last quarter is 316.19 M USD, and it's 1739.07% higher compared to the previous quarter. The net income of Q4 23 is 142.80 M USD.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth